Wells Fargo analyst Stan Berenshteyn lowered the firm’s price target on Accolade to $10 from $12 and keeps an Equal Weight rating on the shares after its Q4 earnings miss. The company’s directional momentum into FY25 trended alongside consensus expectations, coming in a bit better on margins and a bit worse on revenue, the analyst tells investors in a research note. Accolade appears to be navigating an increasingly competitive market, but the pacing of revenue growth longer term remains an area of uncertainty, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
- Accolade price target lowered to $13 from $17 at Needham
- Accolade price target lowered to $16 from $18 at Canaccord
- Accolade price target lowered to $11 from $13 at Barclays
- Accolade sees FY24 revenue $480M-$500M, consensus $413.5M
